The estimated Net Worth of David Scott Tomsche is at least $360 Tysiąc dollars as of 11 March 2020. David Tomsche owns over 4,600 units of Immucell stock worth over $324,117 and over the last 17 years he sold ICCC stock worth over $0. In addition, he makes $36,000 as Chairman of the Board at Immucell.
Sign up
David Tomsche ICCC stock SEC Form 4 insiders trading
David has made over 22 trades of the Immucell stock since 2007, according to the Form 4 filled with the SEC. Most recently he bought 4,600 units of ICCC stock worth $19,688 on 11 March 2020.
The largest trade he's ever made was buying 15,000 units of Immucell stock on 19 August 2011 worth over $87,000. On average, David trades about 2,515 units every 130 days since 2007. As of 11 March 2020 he still owns at least 85,519 units of Immucell stock.
You can see the complete history of David Tomsche stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Tomsche biography
Dr. David Scott Tomsche serves as Chairman of the Board of the Company. Dr. Tomsche was appointed to serve as Chair of the Board of Directors in February 2013. He served on the Nominating Committee of the Board of Directors until September 2017. He served on the Audit Committee from February 2014 through March 2014. He is a large animal veterinarian and owner of Leedstone Inc. (formerly Stearns Veterinary Outlet, Inc., an animal health distribution and milking system installation company) and of J-t Enterprises of Melrose, Inc., an exporter of ImmuCell products. He served as a director of VetPharm, Inc., an animal health products distributor, from 1995 until the company was sold in 2007. He also is a dairy producer. He obtained his degrees from the University of Minnesota.
What is the salary of David Tomsche?
As the Chairman of the Board of Immucell, the total compensation of David Tomsche at Immucell is $36,000. There are 7 executives at Immucell getting paid more, with Michael F. Brigham having the highest compensation of $354,272.
How old is David Tomsche?
David Tomsche is 63, he's been the Chairman of the Board of Immucell since 2017. There are 4 older and 6 younger executives at Immucell. The oldest executive at Immucell Corp. is Jonathan Rothschild, 66, who is the Independent Director.
What's David Tomsche's mailing address?
David's mailing address filed with the SEC is C/O IMMUCELL CORPORATION, 56 EVERGREEN DRIVE, PORTLAND, ME, 04103.
Insiders trading at Immucell
Over the last 21 years, insiders at Immucell have traded over $168,227 worth of Immucell stock and bought 568,684 units worth $2,330,117 . The most active insiders traders include Jonathan E Rothschild, Norman H Pessin oraz Joseph H Crabb. On average, Immucell executives and independent directors trade stock every 50 days with the average trade being worth of $22,979. The most recent stock trade was executed by David Cunningham on 13 June 2022, trading 1,000 units of ICCC stock currently worth $8,000.
What does Immucell do?
immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.
What does Immucell's logo look like?
Complete history of David Tomsche stock trades at Immucell
Immucell executives and stock owners
Immucell executives and other stock owners filed with the SEC include:
-
Michael F. Brigham,
Pres, CEO, Principal Financial Officer, Treasurer, Sec. & Director -
Michael Brigham,
President, Chief Executive Officer, Treasurer, Secretary, Director -
Bobbi Brockmann,
Vice President - Sales and Marketing, Director -
Elizabeth Williams,
Vice President - Manufacturing Operations -
Elizabeth L. Williams,
VP of Manufacturing Operations -
Dr. Joseph H. Crabb Ph.D.,
VP & Chief Scientific Officer -
Joseph Crabb,
Chief Scientific Officer, Vice President -
David Tomsche,
Chairman of the Board -
Paul Wainman,
Independent Director -
Jonathan Rothschild,
Independent Director -
Steven Rosgen,
Independent Director -
David Cunningham,
Independent Director -
John W. Zinckgraf,
Director of Product Devel. -
A. Gustavo Scaffa,
Sr. Director of Quality -
Elizabeth S. Toothaker,
Director of Fin. & Admin. -
Linda Rhodes,
Director -
Brian L. Pessin,
-
Norman H Pessin,
-
Gloria F Basse,
Director -
Anthony B Cashen,
Director -
Robert C Bruce,
Director -
William H Maxwell,
Director -
Bryan K. Gathagan,